Skip to main content

Advertisement

Articles

Page 4 of 4

  1. Ibuprofen is known to be efficacious in the treatment of tension-type headache, the most common form of primary headache. A novel tablet formulation of ibuprofen sodium is more rapidly absorbed than standard i...

    Authors: Elias Packman, Rina Leyva and David Kellstein

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:13

    Content type: Research article

    Published on:

  2. Effect of statin therapy has been reported to be associated with patient’s adherence. Atorvastatin was available in Japan as a brand-name product beginning in 2000. The first atorvastatin generics were introdu...

    Authors: Yasunari Mano, Shota Fukushima, Hisayuki Kuroda, Hiroyuki Ohshima, Yoshinori Kato, Kaori Ohuchi, Kayoko Maezawa, Yasuyuki Momose, Shunya Ikeda and Mariko Asahi

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:12

    Content type: Research article

    Published on:

  3. There are many reports regarding various medical institutions’ attempts at incident prevention, but the relationship between incident types and impact on patients in drug name errors has not been studied. Ther...

    Authors: Toshikazu Tsuji, Toshihiro Irisa, Shunichi Ohata, Chiyo Kokubu, Akiko Kanaya, Masanori Sueyasu, Nobuaki Egashira and Satohiro Masuda

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:11

    Content type: Research article

    Published on:

  4. Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different con...

    Authors: Yoshinori Onuki, Naoki Hasegawa, Chihiro Kida, Mayumi Ikegami-Kawai, Masayoshi Tsubuki, Shunsuke Shirozu, Yasuko Obata and Kozo Takayama

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:9

    Content type: Research article

    Published on:

  5. It is important for pharmacists to manage cancer chemotherapy regimens in order to achieve safe treatment. We examined whether there was a useful pharmacoeconomic benefit of compliance the exclusion criteria o...

    Authors: Makoto Hayashi, Akimasa Yamatani, Hiromu Funaki and Kenichi Miyamoto

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:10

    Content type: Research article

    Published on:

    The Erratum to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2016 2:3

  6. Crizotinib, an ATP-competitive receptor tyrosine kinase inhibitor of both anaplastic lymphoma kinase (ALK) and the hepatocyte growth factor receptor, commonly causes several adverse events (AEs). The clinical ...

    Authors: Yasuko Kurata, Narumi Miyauchi, Manabu Suno, Takahiro Ito, Toshiaki Sendo and Katsuyuki Kiura

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:8

    Content type: Short report

    Published on:

  7. It is well known that molecular-targeted drugs, of which sorafenib (Nexavar®) is one, differ from previous anticancer drugs and cause various unusual adverse drug reactions. Treatment with sorafenib causes adv...

    Authors: Makoto Kajizono, Megumu Aoyagi, Yoshihisa Kitamura and Toshiaki Sendo

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:6

    Content type: Research article

    Published on:

  8. The lower urinary tract symptoms (LUTS) increases with age and can have a significant effect on the quality of life of the patients. Elderly patients, who are often characterized by a decline in physiological ...

    Authors: Masako Hashimoto, Kanako Hashimoto, Fumihiko Ando, Yoshiaki Kimura, Keisuke Nagase and Kunizo Arai

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:7

    Content type: Research article

    Published on:

  9. Tramadol ((±)-TRA) is recommended for the treatment of mild to moderate cancer pain by the World Health Organization. An oral liquid formulation of (±)-TRA is preferable for patients with a compromised swallow...

    Authors: Manabu Suno, Hidenori Ichihara, Takahiro Ishino, Kento Yamamoto and Yuta Yoshizaki

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:5

    Content type: Research article

    Published on:

  10. Delirium is an acute change in cognition and concentration that complicates the postoperative course. Patients who suffer delirium after surgery have an increased risk of persistent cognitive impairment, funct...

    Authors: Kiminaka Murakawa, Yoshihisa Kitamura, Saori Watanabe, Shiho Hongo, Kazuaki Shinomiya and Toshiaki Sendo

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:4

    Content type: Research article

    Published on:

  11. In the construction of pharmacoeoconomic models, simplicity is desirable for transparency (people can see how the model is built), ease of analysis, validation (how well the model reproduces reality), and desc...

    Authors: Takeshi Uchikura, Makoto Kobayashi, Masayuki Hashiguchi and Mayumi Mochizuki

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:3

    Content type: Research article

    Published on:

  12. To improve the adherence to and knowledge about pharmacotherapy in outpatients and to maximize the efficacy and minimize the adverse drug events, the first pharmacist-managed clinic (PMC) in Japan was establis...

    Authors: Kiyofumi Yamada and Toshitaka Nabeshima

    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:2

    Content type: Review

    Published on:

Official journal of JSPHCS

Annual Journal Metrics

  • Speed
    42 days to first decision for reviewed manuscripts only
    41 days to first decision for all manuscripts
    96 days from submission to acceptance
    29 days from acceptance to publication

    Usage 
    98,525 Downloads
    93 mentions

Advertisement